Pediatric oncology is a specialized branch of cancer research focused on diagnosing and treating cancers in children. Unlike adult cancers, pediatric cancers often have distinct biological characteristics, making their treatment and prognosis different. Researchers in this field aim to understand the genetic and molecular drivers of childhood cancers, such as leukemia, brain tumors, and neuroblastoma, to develop more effective, less toxic therapies. Advances in pediatric oncology have led to significant improvements in survival rates, but challenges remain in reducing long-term side effects from treatments. Ongoing studies emphasize precision medicine, genetic therapies, and novel drug development to provide better outcomes for young patients. Collaborative efforts between research institutes, healthcare providers, and families play a crucial role in advancing pediatric oncology and ensuring a brighter future for children battling cancer.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : A case-based approach using IMPeTUs criteria in FDG PET/CT reporting of multiple myeloma
Mudalsha Ravina, All India Institute of Medical Sciences, India
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Transforming cancer care: Innovations, integrations, and impact
Shayan Maqsood, Jamia Hamdard University, India
Title : Genetic and epigenetic alterations of SOX7 in multiple myeloma and allied neoplasms
Can Küçük, Dokuz Eylul University, Turkey
Title : Advanced nanoparticles, the hallmark of targeted drug delivery for osteosarcoma
Shayan Maqsood, Jamia Hamdard University, India